Related Experiment Video
Updated: Jun 7, 2025

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
[Use of the drug Prostatex plus in patients with chronic abacterial prostatitis and BPH]
I Neymark A1,2,3, A Nozdrachev N1,2,3, V Kulchavenya E1,2,3
1Department of Urology and Andrology with a course of Specialized Surgery of Altai State Medical University of the Ministry of Health of Russia, Barnaul, Russia.
Aim:
To evaluate the efficiency of therapy with Prostatex plus rectal suppositories in the treatment of patients with chronic abacterial prostatitis and benign prostatic hyperplasia (BPH).
Materials And Methods:
A total of 50 men with chronic abacterial prostatitis of category III A, occurring in combination with BPH, were included in the study. All patients received Prostatex plus (rectal suppositories) 1 suppository 1 time per day. The duration of treatment was 20 days. After taking the drug, patients were followed-up for 40 days. There were three follow-up visits during the study period (days 1, 20 and 60).
Results:
The study proved that the use of Prostatex plus rectal suppositories has a positive effect on urinary parameters, subjective and objective symptoms of chronic abacterial prostatitis and BPH, which allowed to recommend it for this group of patients, according to the following scheme: 1 suppository 1 time per day for 20 days.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

